PT - JOURNAL ARTICLE AU - Rachel Butcher AU - Norman Fenton TI - Extending the range of symptoms in a Bayesian Network for the Predictive Diagnosis of COVID-19 AID - 10.1101/2020.10.22.20217554 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.22.20217554 4099 - http://medrxiv.org/content/early/2020/10/26/2020.10.22.20217554.short 4100 - http://medrxiv.org/content/early/2020/10/26/2020.10.22.20217554.full AB - Emerging digital technologies have taken an unprecedented position at the forefront of COVID-19 management. This paper extends a previous Bayesian network designed to predict the probability of COVID-19 infection, based on a patient’s profile. The structure and prior probabilities have been amalgamated from the knowledge of peer-reviewed articles. The network accounts for demographics, behaviours and symptoms, and can mathematically identify multivariate combinations with the highest risk. Potential applications include patient triage in healthcare systems or embedded software for contact-tracing apps. Specifically, this paper extends the set of symptoms that are a marker for COVID-19 infection and the differential diagnosis of other conditions with similar presentations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials.